Pathstone Holdings’s Acumen Pharmaceuticals ABOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.23M | Sell |
1,058,531
-28,000
| -3% | -$32.5K | ﹤0.01% | 1284 |
|
|
2025
Q1 | $1.2M | Buy |
1,086,531
+479,686
| +79% | +$528K | 0.01% | 1286 |
|
|
2024
Q4 | $1.04M | Buy |
606,845
+89,562
| +17% | +$154K | ﹤0.01% | 1350 |
|
|
2024
Q3 | $1.28M | Buy |
517,283
+37,060
| +8% | +$91.9K | 0.01% | 1231 |
|
|
2024
Q2 | $1.16M | Buy |
480,223
+42
| +0% | +$102 | 0.01% | 1237 |
|
|
2024
Q1 | $1.94M | Buy |
480,181
+1,032
| +0.2% | +$4.18K | 0.01% | 916 |
|
|
2023
Q4 | $1.84M | Buy |
+479,149
| New | +$1.84M | 0.01% | 776 |
|